2014Medical Innovation of ChinaRequires access

Infection Distribution and Drug Resistance Analysis of 91 Strains of Acinetobacter Baumannii

Yongju Chen

Open publisher page 0 citations

Abstract

Objective:To study Acinetobacter baumannii infection and drug resistance for clinical rational use of antibiotics and provide scientific basis.Method: 91 strains of Acinetobacter baumannii by clinical isolates in our hospital were collected, its distribution department, source of specimen and drug resistance were analyzed.Result: Acinetobacter baumannii mainly neurosurgery ward, dry attending three wards and respiratory wards were 26.4%, with a maximum separation of sputum was 87.9%; piperazine to amoxicillin / tazobactam rate was 32.8%, asia imipenem and meropenem resistance rates was 34.0%.Conclusion:Acinetobacter baumannii is a complex resistance mechanisms should be strengthened to monitor drug-resistant strains of hospital, clinical rational use of antibiotics, take effective preventive measures to minimize Pseudomonas aeruginosa infection.

About this research paper

What this paper is about

Objective:To study Acinetobacter baumannii infection and drug resistance for clinical rational use of antibiotics and provide scientific basis.Method: 91 strains of Acinetobacter baumannii by clinical isolates in our hospital were collected, its distribution department, source of specimen and drug resistance were analyzed.Result: Acinetobacter baumannii mainly neurosurgery ward, dry attending three wards and respiratory wards were 26.4%, with a maximum separation of sputum was 87.9%; piperazine to amoxicillin / tazobactam rate was 32.8%, asia imipenem and meropenem resistance rates was 34.0%.Conclusion:Acinetobacter baumannii is a complex resistance mechanisms should be strengthened to monitor drug-resistant strains of hospital, clinical rational use of antibiotics, take effective preventive measures to minimize Pseudomonas aeruginosa infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study Acinetobacter baumannii infection and drug resistance for clinical rational use of antibiotics and provide scientific basis.Method: 91 strains of Acinetobacter baumannii by clinical isolates in our hospital were collected, its distribution department, source of specimen and drug resistance were analyzed.Result: Acinetobacter baumannii mainly neurosurgery ward, dry attending three wards and respiratory wards were 26.4%, with a maximum separation of sputum was 87.9%; piperazine to amoxicillin / tazobactam rate was 32.8%, asia imipenem and meropenem resistance rates was 34.0%.Conclusion:Acinetobacter baumannii is a complex resistance mechanisms should be strengthened to monitor drug-resistant strains of hospital, clinical rational use of antibiotics, take effective preventive measures to minimize Pseudomonas aeruginosa infection.

Key concepts: Acinetobacter baumannii, Medicine, Meropenem, Imipenem, Drug resistance, Tazobactam, Microbiology, Pseudomonas aeruginosa

Related papers

Back to paper searchBrowse research topicsOriginal source
Infection Distribution and Drug Resistance Analysis of 91 Strains of Acinetobacter Baumannii — Research Paper | ScholarLens